TherapeuticsMD (TXMD) Reports Q1 Loss of $0.24/sh

TherapeuticsMD (NASDAQ: TXMD) reported Q1 EPS of ($0.24), versus ($2.08) reported last year. Revenue for the quarter came in at $400 thousand, versus $700 thousand reported last year.

For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• C3.ai (AI) Tops Q1 EPS by 5c; Offers Guidance
• Ollie's Bargain Outlet (OLLI) Tops Q2 EPS by 28c, Offers Guidance